Zhiguo Chen

Zhiguo Chen

University of Florida

H-index: 13

North America-United States

About Zhiguo Chen

Zhiguo Chen, With an exceptional h-index of 13 and a recent h-index of 12 (since 2020), a distinguished researcher at University of Florida, specializes in the field of Statistics and Machine learning.

His recent articles reflect a diverse array of research interests and contributions to the field:

MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231

Development of osteonecrosis and improved survival in B-ALL: results of Children’s Oncology Group Trial AALL0232

Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group

Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children’s Oncology Group study

Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia

A phase 3 trial of inotuzumab ozogamicin for high-risk B-ALL: Second safety phase results from Children’s Oncology Group AALL1732.

Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children’s Oncology Group report

Racial and Ethnic Disparities in Childhood and Young Adult Acute Lymphoblastic Leukaemia: A Children’s Oncology Group Cohort Study

Zhiguo Chen Information

University

Position

___

Citations(all)

892

Citations(since 2020)

854

Cited By

218

hIndex(all)

13

hIndex(since 2020)

12

i10Index(all)

14

i10Index(since 2020)

14

Email

University Profile Page

Google Scholar

Zhiguo Chen Skills & Research Interests

Statistics and Machine learning

Top articles of Zhiguo Chen

MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231

Blood Journal

2024/3/8

Development of osteonecrosis and improved survival in B-ALL: results of Children’s Oncology Group Trial AALL0232

Leukemia

2024/2

Zhiguo Chen
Zhiguo Chen

H-Index: 6

Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group

Journal of Clinical Oncology

2024/1/10

Zhiguo Chen
Zhiguo Chen

H-Index: 6

I-Ming Chen
I-Ming Chen

H-Index: 29

Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children’s Oncology Group study

Blood

2023/12/14

Zhiguo Chen
Zhiguo Chen

H-Index: 6

A phase 3 trial of inotuzumab ozogamicin for high-risk B-ALL: Second safety phase results from Children’s Oncology Group AALL1732.

2023/6/1

Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children’s Oncology Group report

Blood

2023/4/13

Zhiguo Chen
Zhiguo Chen

H-Index: 6

Racial and Ethnic Disparities in Childhood and Young Adult Acute Lymphoblastic Leukaemia: A Children’s Oncology Group Cohort Study

The Lancet Haematology

2023/2/1

Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group

Pediatric blood & cancer

2022/11

Children's Oncology Group Trial AALL1231: a phase III clinical trial testing bortezomib in newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma

Journal of Clinical Oncology

2022/7/7

Zhiguo Chen
Zhiguo Chen

H-Index: 6

Neelam Singh
Neelam Singh

H-Index: 3

Effects of age, obesity, and body surface area on asparaginase-associated toxicities during acute lymphoblastic leukemia induction therapy: A report from the Children’s …

2022/6/1

Sex‐based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children’s Oncology Group report

Cancer

2022/5/1

Sumit Gupta
Sumit Gupta

H-Index: 16

Zhiguo Chen
Zhiguo Chen

H-Index: 6

Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: Report from Children’s Oncology …

Leukemia

2022/3

Zhiguo Chen
Zhiguo Chen

H-Index: 6

A Transcriptional Classifier Identifies Pediatric T-Cell Acute Lymphoblastic Leukemias at High Risk for End of Induction Minimal Residual Disease

Blood

2022/11/15

Correlation of Minimal Residual Disease (MRD) at the End of Induction (EOI) and Event Free Survival (EFS) in T-Cell Lymphoblastic Lymphoma (T-LL), a Report from the Children's …

Blood

2022/11/15

Zhiguo Chen
Zhiguo Chen

H-Index: 6

Neelam Singh
Neelam Singh

H-Index: 3

Intensification of chemotherapy using a modified BFM backbone for children, adolescents and young adults with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell …

Blood

2021/11/23

Zhiguo Chen
Zhiguo Chen

H-Index: 6

A phase 3 randomized trial of Inotuzumab Ozogamicin for newly diagnosed high-risk B-ALL: safety phase results from children's oncology group protocol AALL1732

Blood

2021/11/23

Zhiguo Chen
Zhiguo Chen

H-Index: 6

Sarah Alexander
Sarah Alexander

H-Index: 3

Prognostic Impact of CNS-2 status in T-ALL: A report from the Children’s Oncology Group.

2021/5/20

See List of Professors in Zhiguo Chen University(University of Florida)